The conduct of clinical trials is a critical process. Along with resource hiring, it also requires materials for different activities. Some of these materials can be investigational products. But, a vast number of products could be non-investigational products necessary for the conduct of clinical trials. It becomes critical to plan for procurement or import of […]

Read More →

The drug approval process in Japan is less complex and easy when compared to some other countries beyond the language barriers. In addition to regulatory considerations, the PMDA offers sponsors consultation to assist them in understanding the prerequisites and the detailed procedure for drug approval. As a result of this positive change, many manufacturers choose […]

Read More →

Regulatory agencies in various countries are providing benefits & regulatory incentives for orphan drugs such as faster approvals, fee concessions, and financial benefits, and many more. These incentives are to support and encourage pharma companies to work on developing orphan drugs or medical devices for rare diseases. The countries that provide regulatory incentives include the […]

Read More →

Japan has clear and well-structured regulations for clinical trials. These rules help ensure the safety and effectiveness of new drugs. The government provides guidelines that drug developers must follow. The approval process is efficient, making Japan an attractive location for clinical trials. With a large market and strong regulatory support, Japan offers many benefits for […]

Read More →